- Market Realist•6 days ago
23.1% of analysts gave United Therapeutics (UTHR) a “buy” recommendation while 69.2% of analysts rated the company a “hold.”
- Zacks•7 days ago
The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
After hours: 88.720.00 (0.00%) as of 4:42 PM EDT
|Bid||71.17 x 100|
|Ask||89.50 x 300|
|52wk Range||55.00 - 133.62|
|Day's Range||87.24 - 89.15|
|Avg Vol (3m)||1,084,676|
As of 4:00 PM EDT. Market closed.